News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Asterand plc (ATD.L) Subsidiary BioSeek, LLC. and US FDA Expand ToxCast™ Collaboration


1/31/2012 9:21:49 AM

DETROIT--(BUSINESS WIRE)--Asterand plc (LSE: ATD) today announced that the U.S. Environmental Protection Agency (EPA) has expanded its collaboration and Phase II funding commitment with Asterand’s subsidiary BioSeek LLC. Under the EPA ToxCast™ screening program, BioSeek is employing its unique BioMAP® Systems human primary cell assay platform to predict the biological activity and potential toxicity of environmental and other chemicals on human health. The new agreement provides $696,000 in additional funding for BioSeek and adds a further 100 compounds to the more than 1000 environmental compounds, pesticides, failed pharmaceuticals, and nanomaterials already analyzed using BioMAP Systems in this ongoing effort.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES